Is Anifrolumab an effective treatment for lupus nephritis?
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation...
4 Joulu 202312min
Which one is better at controlling lupus: Belimumab or Anifrolumab?
Dr. Anna Wolska sits down with experts, Dr. Michelle Petri and Dr. Nick Ballew, analyzing the effectiveness of SLE treatments Belimumab and Anifrolumab. The conversation delves into their meticulous s...
7 Marras 202312min
Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to understand progression of lupus nephritis over time. They o...
2 Loka 202323min
Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Anca Askanase and Joan Merrill, the developers of the LFA-REAL tool. Together, they discuss the importance of using a tool like LFA...
4 Syys 202318min
Understanding Lupus: Exploring the Differences between Type 1 and Type 2 Symptoms
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Amrie Grammer and Dr. Peter Lipsky from AMPEL BioSolutions. Together they describe the molecular endotypes of Type 1 and Type 2 Syst...
7 Elo 202320min
Unpacking Lupus Treatment: How Quickly Does Anifrolumab Start Working? Insights from TULIP Trials
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in ...
3 Heinä 202314min
Biomarker reduction indicates treatment response to Belimumab
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee...
24 Touko 202314min
Mesenchymal stromal cells: a potential new SLE treatment option?
Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I trial into the use of mesenchymal stromal cells (MSC) in ref...
2 Elo 202217min
